Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Hikal Limited, commonly referred to as Hikal, is a prominent player in the pharmaceutical preparation manufacturing industry, with its headquarters based in India. Established in 1988, the company has grown to serve a diverse global client base, primarily across North America, Europe, and Asia. Hikal specialises in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and custom synthesis services, recognised for their high quality and compliance with international standards.
With a strong focus on innovation and regulatory excellence, Hikal has earned a notable reputation within the pharmaceutical sector. Its strategic milestones include expanding its manufacturing capabilities and establishing a robust presence in the global pharmaceutical supply chain. As a key industry participant, Hikal continues to advance its offerings, supporting the development of life-saving medicines worldwide.
-8 vs industry average
Hikal’s score of 34 is lower than 46% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Hikal, a Pharmaceutical Preparation Manufacturing company based in India, reported its Scope 1 emissions for 2024 as 21,410,710 kg CO2e and Scope 2 emissions as 67,287,010 kg CO2e. For 2023, the company's Scope 1 emissions were 26,793,240 kg CO2e and Scope 2 emissions were 67,737,300 kg CO2e. In 2022, Hikal's Scope 1 emissions were 57,457,000 kg CO2e; Scope 2 and 3 data were not disclosed for this year.
Hikal is committed to an ambitious decarbonisation journey, aiming to achieve a 30% reduction in Scope 1 and 2 emissions by the 2027-28 financial year, compared to 2022-23 levels. The company has also committed to setting science-based targets, as confirmed by the Science Based Targets initiative (SBTi).
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Hikal’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more